Long term follow-up data of @ healthy women with baseline plasma samples in the Women 's Health Study , a randomised trial of @mg alternate-day aspirin versus placebo , were used to develop competing risks models for individualised prediction of absolute risk reduction of the combination of CVD , cancer and major gastrointestinal bleeding by aspirin .